Detalhe da pesquisa
1.
[Distribution of the Prevalence of Human Leukocyte Antigen (HLA)-B*57:01 Positivity in HIV-1 Infected Individuals and Its Effects on Treatment: Türkiye Map-Buhasder Working Group]. / HIV-1 Enfekte Bireylerde Insan Lökosit Antijeni (HLA)-B*57:01 Pozitifligi Prevalansinin Dagilimi ve Tedavi Üzerine Etkileri: Türkiye Haritasi-BUHASDER Çalisma Grubu.
Mikrobiyol Bul
; 58(1): 29-38, 2024 Jan.
Artigo
em Turco
| MEDLINE | ID: mdl-38263938
2.
Clinicopathological profile of peritoneal tuberculosis and a new scoring model for predicting mortality: an international ID-IRI study.
Eur J Clin Microbiol Infect Dis
; 42(8): 981-992, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37318601
3.
Tocilizumab treatment in severe COVID-19: a multicenter retrospective study with matched controls.
Rheumatol Int
; 42(3): 457-467, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34515808
4.
Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study.
Turk J Med Sci
; 52(5): 1486-1494, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36422492
5.
Evaluation of 17 patients with COVID-19 pneumonia treated with anakinra according to HScore, SOFA, MuLBSTA, and Brescia-COVID respiratory severity scale (BCRSS) scoring systems.
J Med Virol
; 93(3): 1532-1537, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32860431
6.
Development and validation of nomogram to predict severe illness requiring intensive care follow up in hospitalized COVID-19 cases.
BMC Infect Dis
; 21(1): 1004, 2021 Sep 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34563117
7.
The Effect of prolonged PCR Positivity on patient Outcomes and Determination of Isolation period in COVID-19 patients.
Int J Clin Pract
; 75(5): e14025, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33449410
8.
COVID-19 experience of the major pandemic response center in the capital: results of the pandemic's first month in Turkey
Turk J Med Sci
; 50(8): 1801-1809, 2020 12 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32682358
9.
Hematological findings in children with brucellosis.
Pediatr Int
; 57(6): 1108-11, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25980959
10.
Clinical and laboratory features of adult measles cases detected in Van, Turkey.
J Pak Med Assoc
; 65(3): 273-6, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25933560
11.
Insights from 3D modeling and fluid dynamics in COVID-19 pneumonia.
Med Biol Eng Comput
; 62(2): 621-636, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37980307
12.
An investigation of clinical characteristics and antimicrobial agent susceptibility patterns in clinical Comamonas testosteroni isolates: An increasingly prevalent nosocomial pathogen.
Infect Dis Now
; 53(2): 104622, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36245130
13.
Investigating Whether the Severity of SARS-CoV-2 Infection Is Higher in Liver Transplant Recipients: A Single-Center Experience.
Exp Clin Transplant
; 21(10): 837-840, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35297331
14.
Secondary infections in cancer patients with febrile neutropenia.
Turk J Haematol
; 29(3): 254-8, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24744669
15.
Correlation of olfactory dysfunction with lung involvement and severity of COVID-19.
Ir J Med Sci
; 191(4): 1843-1848, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-34374938
16.
Secondary bacterial infections of the respiratory tract in COVID-19 patients.
J Infect Dev Ctries
; 16(7): 1131-1137, 2022 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35905017
17.
The predictive value of epicardial fat volume for clinical severity of COVID-19.
Rev Port Cardiol
; 41(9): 729-737, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35505820
18.
Effect of chronic lung diseases on mortality of prevariant COVID-19 pneumonia patients.
Front Med (Lausanne)
; 9: 957598, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36314036
19.
A useful and sensitive marker in the prediction of COVID-19 and disease severity: Thiol.
Free Radic Biol Med
; 166: 11-17, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33588050
20.
Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravir.
J Infect Public Health
; 14(3): 365-370, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33647553